Drug use and self-reported HIV serostatus of clients entering methadone treatment programs in New England. (Research Report)

AUTHORS: R. MacGowan( 1), G. Cole( 1), J. Scibak( 2). (1)U.S. Centers for Disease Control and Prevention, Atlanta, Georgia; (2)Providence Hospital, Holyoke, Massachusetts.

According to an abstract submitted to the 120th Annual Meeting of the American Public Health Association held November 8-12, 1992, in Washington, D.C., "We examined drug use of clients entering drug treatment in central Massachusetts and Connecticut by their self-reported HIV serostatus. Persons entering treatment (n=636) between 6/90 and 1/92, were asked to report which drug they used for the 30 days prior to treatment, number of days each was used, frequency of injection and HIV serostatus. Of …